nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP1A1—Nicotine—ulcerative colitis	0.0964	0.122	CbGbCtD
Flutamide—CYP1A1—Cholecalciferol—ulcerative colitis	0.0865	0.109	CbGbCtD
Flutamide—CYP1B1—Dexamethasone—ulcerative colitis	0.0853	0.108	CbGbCtD
Flutamide—CYP3A4—Budesonide—ulcerative colitis	0.0518	0.0656	CbGbCtD
Flutamide—CYP2C19—Nicotine—ulcerative colitis	0.0467	0.0591	CbGbCtD
Flutamide—CYP3A5—Sulfasalazine—ulcerative colitis	0.045	0.057	CbGbCtD
Flutamide—CYP1A2—Nicotine—ulcerative colitis	0.0431	0.0545	CbGbCtD
Flutamide—CYP2C19—Cholecalciferol—ulcerative colitis	0.0419	0.053	CbGbCtD
Flutamide—CYP1A1—Dexamethasone—ulcerative colitis	0.0374	0.0474	CbGbCtD
Flutamide—CYP3A5—Hydrocortisone—ulcerative colitis	0.0361	0.0457	CbGbCtD
Flutamide—CYP2C19—Prednisone—ulcerative colitis	0.029	0.0367	CbGbCtD
Flutamide—CYP3A4—Methylprednisolone—ulcerative colitis	0.0232	0.0293	CbGbCtD
Flutamide—CYP3A4—Nicotine—ulcerative colitis	0.0226	0.0286	CbGbCtD
Flutamide—CYP3A5—Dexamethasone—ulcerative colitis	0.0225	0.0284	CbGbCtD
Flutamide—CYP3A4—Cholecalciferol—ulcerative colitis	0.0202	0.0256	CbGbCtD
Flutamide—CYP2C19—Dexamethasone—ulcerative colitis	0.0181	0.0229	CbGbCtD
Flutamide—CYP3A4—Triamcinolone—ulcerative colitis	0.0175	0.0222	CbGbCtD
Flutamide—CYP3A4—Betamethasone—ulcerative colitis	0.0151	0.0191	CbGbCtD
Flutamide—CYP3A4—Prednisolone—ulcerative colitis	0.0149	0.0188	CbGbCtD
Flutamide—CYP3A4—Hydrocortisone—ulcerative colitis	0.0141	0.0178	CbGbCtD
Flutamide—CYP3A4—Prednisone—ulcerative colitis	0.014	0.0178	CbGbCtD
Flutamide—CYP3A4—Dexamethasone—ulcerative colitis	0.00876	0.0111	CbGbCtD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.00127	0.0415	CbGpPWpGaD
Flutamide—AR—Nuclear Receptors—NR5A2—ulcerative colitis	0.00108	0.0354	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—MIF—ulcerative colitis	0.000999	0.0326	CbGpPWpGaD
Flutamide—AR—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.000857	0.028	CbGpPWpGaD
Flutamide—AR—FOXA1 transcription factor network—COL18A1—ulcerative colitis	0.000753	0.0246	CbGpPWpGaD
Flutamide—AR—Nuclear Receptors—HNF4A—ulcerative colitis	0.000606	0.0198	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—PARK7—ulcerative colitis	0.000584	0.0191	CbGpPWpGaD
Flutamide—Tension—Budesonide—ulcerative colitis	0.00057	0.00327	CcSEcCtD
Flutamide—Feeling abnormal—Nicotine—ulcerative colitis	0.000567	0.00325	CcSEcCtD
Flutamide—Nervousness—Budesonide—ulcerative colitis	0.000564	0.00323	CcSEcCtD
Flutamide—Increased appetite—Triamcinolone—ulcerative colitis	0.000559	0.0032	CcSEcCtD
Flutamide—Increased appetite—Methylprednisolone—ulcerative colitis	0.000558	0.0032	CcSEcCtD
Flutamide—Dermatitis bullous—Triamcinolone—ulcerative colitis	0.00055	0.00315	CcSEcCtD
Flutamide—Diabetes mellitus—Betamethasone—ulcerative colitis	0.000548	0.00314	CcSEcCtD
Flutamide—Diabetes mellitus—Dexamethasone—ulcerative colitis	0.000548	0.00314	CcSEcCtD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.000547	0.0179	CbGpPWpGaD
Flutamide—Hepatitis—Mesalazine—ulcerative colitis	0.000543	0.00311	CcSEcCtD
Flutamide—AHR—smooth muscle tissue—ulcerative colitis	0.000542	0.111	CbGeAlD
Flutamide—AHR—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	0.00054	0.0176	CbGpPWpGaD
Flutamide—Ill-defined disorder—Budesonide—ulcerative colitis	0.000539	0.00309	CcSEcCtD
Flutamide—Anaemia—Budesonide—ulcerative colitis	0.000537	0.00308	CcSEcCtD
Flutamide—Oedema peripheral—Mesalazine—ulcerative colitis	0.000535	0.00306	CcSEcCtD
Flutamide—AHR—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	0.000525	0.0171	CbGpPWpGaD
Flutamide—Malaise—Budesonide—ulcerative colitis	0.000524	0.003	CcSEcCtD
Flutamide—Ecchymosis—Prednisone—ulcerative colitis	0.000517	0.00296	CcSEcCtD
Flutamide—Increased appetite—Betamethasone—ulcerative colitis	0.000507	0.00291	CcSEcCtD
Flutamide—Increased appetite—Dexamethasone—ulcerative colitis	0.000507	0.00291	CcSEcCtD
Flutamide—Hypertension—Budesonide—ulcerative colitis	0.000502	0.00287	CcSEcCtD
Flutamide—Dermatitis bullous—Betamethasone—ulcerative colitis	0.000499	0.00286	CcSEcCtD
Flutamide—Dermatitis bullous—Dexamethasone—ulcerative colitis	0.000499	0.00286	CcSEcCtD
Flutamide—AR—Notch-mediated HES/HEY network—MAML2—ulcerative colitis	0.000498	0.0163	CbGpPWpGaD
Flutamide—Asthenia—Nicotine—ulcerative colitis	0.000494	0.00283	CcSEcCtD
Flutamide—Anxiety—Budesonide—ulcerative colitis	0.000493	0.00282	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000491	0.00281	CcSEcCtD
Flutamide—Discomfort—Budesonide—ulcerative colitis	0.000489	0.0028	CcSEcCtD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000488	0.0159	CbGpPWpGaD
Flutamide—Pruritus—Nicotine—ulcerative colitis	0.000487	0.00279	CcSEcCtD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.000486	0.0159	CbGpPWpGaD
Flutamide—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000486	0.00278	CcSEcCtD
Flutamide—Ill-defined disorder—Azathioprine—ulcerative colitis	0.000481	0.00276	CcSEcCtD
Flutamide—Anaemia—Azathioprine—ulcerative colitis	0.000479	0.00275	CcSEcCtD
Flutamide—AR—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.000479	0.0156	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—TCF4—ulcerative colitis	0.000478	0.0156	CbGpPWpGaD
Flutamide—Confusional state—Budesonide—ulcerative colitis	0.000478	0.00274	CcSEcCtD
Flutamide—Diabetes mellitus—Prednisone—ulcerative colitis	0.000477	0.00273	CcSEcCtD
Flutamide—Erythema—Mesalazine—ulcerative colitis	0.000472	0.00271	CcSEcCtD
Flutamide—Diarrhoea—Nicotine—ulcerative colitis	0.000471	0.0027	CcSEcCtD
Flutamide—Malaise—Azathioprine—ulcerative colitis	0.000468	0.00268	CcSEcCtD
Flutamide—Leukopenia—Azathioprine—ulcerative colitis	0.000464	0.00266	CcSEcCtD
Flutamide—Tension—Mesalazine—ulcerative colitis	0.000464	0.00266	CcSEcCtD
Flutamide—Skin disorder—Budesonide—ulcerative colitis	0.000461	0.00264	CcSEcCtD
Flutamide—Nervousness—Mesalazine—ulcerative colitis	0.000459	0.00263	CcSEcCtD
Flutamide—Dizziness—Nicotine—ulcerative colitis	0.000455	0.00261	CcSEcCtD
Flutamide—AHR—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	0.000455	0.0149	CbGpPWpGaD
Flutamide—Anorexia—Budesonide—ulcerative colitis	0.000452	0.00259	CcSEcCtD
Flutamide—Vomiting—Mercaptopurine—ulcerative colitis	0.000452	0.00259	CcSEcCtD
Flutamide—Rash—Mercaptopurine—ulcerative colitis	0.000448	0.00257	CcSEcCtD
Flutamide—Dermatitis—Mercaptopurine—ulcerative colitis	0.000448	0.00256	CcSEcCtD
Flutamide—Increased appetite—Prednisone—ulcerative colitis	0.000442	0.00253	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000439	0.00251	CcSEcCtD
Flutamide—Ill-defined disorder—Mesalazine—ulcerative colitis	0.000438	0.00251	CcSEcCtD
Flutamide—Vomiting—Nicotine—ulcerative colitis	0.000438	0.00251	CcSEcCtD
Flutamide—Anaemia—Mesalazine—ulcerative colitis	0.000437	0.0025	CcSEcCtD
Flutamide—Discomfort—Azathioprine—ulcerative colitis	0.000436	0.0025	CcSEcCtD
Flutamide—Rash—Nicotine—ulcerative colitis	0.000434	0.00249	CcSEcCtD
Flutamide—Dermatitis—Nicotine—ulcerative colitis	0.000434	0.00248	CcSEcCtD
Flutamide—Headache—Nicotine—ulcerative colitis	0.000431	0.00247	CcSEcCtD
Flutamide—Insomnia—Budesonide—ulcerative colitis	0.000429	0.00246	CcSEcCtD
Flutamide—AHR—digestive system—ulcerative colitis	0.000428	0.0876	CbGeAlD
Flutamide—Malaise—Mesalazine—ulcerative colitis	0.000426	0.00244	CcSEcCtD
Flutamide—Leukopenia—Mesalazine—ulcerative colitis	0.000423	0.00242	CcSEcCtD
Flutamide—Nausea—Mercaptopurine—ulcerative colitis	0.000422	0.00242	CcSEcCtD
Flutamide—Somnolence—Budesonide—ulcerative colitis	0.000422	0.00241	CcSEcCtD
Flutamide—Thrombocytopenia—Azathioprine—ulcerative colitis	0.000414	0.00237	CcSEcCtD
Flutamide—Decreased appetite—Budesonide—ulcerative colitis	0.000412	0.00236	CcSEcCtD
Flutamide—Skin disorder—Azathioprine—ulcerative colitis	0.000411	0.00236	CcSEcCtD
Flutamide—Nausea—Nicotine—ulcerative colitis	0.000409	0.00234	CcSEcCtD
Flutamide—Fatigue—Budesonide—ulcerative colitis	0.000409	0.00234	CcSEcCtD
Flutamide—Hypertension—Mesalazine—ulcerative colitis	0.000408	0.00234	CcSEcCtD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—ulcerative colitis	0.000406	0.0132	CbGpPWpGaD
Flutamide—Constipation—Budesonide—ulcerative colitis	0.000405	0.00232	CcSEcCtD
Flutamide—Anxiety—Mesalazine—ulcerative colitis	0.000401	0.0023	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000399	0.00229	CcSEcCtD
Flutamide—Discomfort—Mesalazine—ulcerative colitis	0.000397	0.00228	CcSEcCtD
Flutamide—AHR—Circadian rythm related genes—GHRL—ulcerative colitis	0.000391	0.0128	CbGpPWpGaD
Flutamide—Feeling abnormal—Budesonide—ulcerative colitis	0.000391	0.00224	CcSEcCtD
Flutamide—Confusional state—Mesalazine—ulcerative colitis	0.000389	0.00223	CcSEcCtD
Flutamide—Oedema—Mesalazine—ulcerative colitis	0.000386	0.00221	CcSEcCtD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—ulcerative colitis	0.000385	0.0126	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.000379	0.0124	CbGpPWpGaD
Flutamide—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000378	0.00216	CcSEcCtD
Flutamide—AR—Nuclear Receptors—VDR—ulcerative colitis	0.000377	0.0123	CbGpPWpGaD
Flutamide—Skin disorder—Mesalazine—ulcerative colitis	0.000375	0.00215	CcSEcCtD
Flutamide—Hyperglycaemia—Betamethasone—ulcerative colitis	0.000372	0.00213	CcSEcCtD
Flutamide—Hyperglycaemia—Dexamethasone—ulcerative colitis	0.000372	0.00213	CcSEcCtD
Flutamide—Anorexia—Mesalazine—ulcerative colitis	0.000368	0.00211	CcSEcCtD
Flutamide—CYP1B1—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000359	0.0117	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000357	0.0117	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	0.000354	0.0116	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	0.000354	0.0116	CbGpPWpGaD
Flutamide—Feeling abnormal—Azathioprine—ulcerative colitis	0.000349	0.002	CcSEcCtD
Flutamide—Insomnia—Mesalazine—ulcerative colitis	0.000349	0.002	CcSEcCtD
Flutamide—Erythema—Prednisolone—ulcerative colitis	0.000344	0.00197	CcSEcCtD
Flutamide—Somnolence—Mesalazine—ulcerative colitis	0.000343	0.00196	CcSEcCtD
Flutamide—Asthenia—Budesonide—ulcerative colitis	0.00034	0.00195	CcSEcCtD
Flutamide—Erythema—Hydrocortisone—ulcerative colitis	0.000336	0.00192	CcSEcCtD
Flutamide—Pruritus—Budesonide—ulcerative colitis	0.000335	0.00192	CcSEcCtD
Flutamide—Decreased appetite—Mesalazine—ulcerative colitis	0.000335	0.00192	CcSEcCtD
Flutamide—Fatigue—Mesalazine—ulcerative colitis	0.000332	0.0019	CcSEcCtD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—ulcerative colitis	0.000331	0.0108	CbGpPWpGaD
Flutamide—Erectile dysfunction—Prednisone—ulcerative colitis	0.00033	0.00189	CcSEcCtD
Flutamide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.00033	0.0108	CbGpPWpGaD
Flutamide—Constipation—Mesalazine—ulcerative colitis	0.00033	0.00189	CcSEcCtD
Flutamide—Diarrhoea—Budesonide—ulcerative colitis	0.000324	0.00186	CcSEcCtD
Flutamide—Hyperglycaemia—Prednisone—ulcerative colitis	0.000324	0.00185	CcSEcCtD
Flutamide—AR—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.000322	0.0105	CbGpPWpGaD
Flutamide—Ill-defined disorder—Prednisolone—ulcerative colitis	0.000319	0.00183	CcSEcCtD
Flutamide—AHR—liver—ulcerative colitis	0.000319	0.0652	CbGeAlD
Flutamide—Feeling abnormal—Mesalazine—ulcerative colitis	0.000318	0.00182	CcSEcCtD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000317	0.0103	CbGpPWpGaD
Flutamide—Erythema—Triamcinolone—ulcerative colitis	0.000316	0.00181	CcSEcCtD
Flutamide—Erythema—Methylprednisolone—ulcerative colitis	0.000316	0.00181	CcSEcCtD
Flutamide—CYP1B1—Estrogen Receptor Pathway—STAT3—ulcerative colitis	0.000315	0.0103	CbGpPWpGaD
Flutamide—Dizziness—Budesonide—ulcerative colitis	0.000314	0.0018	CcSEcCtD
Flutamide—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.000312	0.00179	CcSEcCtD
Flutamide—Malaise—Prednisolone—ulcerative colitis	0.00031	0.00178	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—MMP1—ulcerative colitis	0.000306	0.00998	CbGpPWpGaD
Flutamide—Malaise—Hydrocortisone—ulcerative colitis	0.000303	0.00174	CcSEcCtD
Flutamide—Vomiting—Budesonide—ulcerative colitis	0.000301	0.00173	CcSEcCtD
Flutamide—Rash—Budesonide—ulcerative colitis	0.000299	0.00171	CcSEcCtD
Flutamide—Dermatitis—Budesonide—ulcerative colitis	0.000299	0.00171	CcSEcCtD
Flutamide—AR—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.000298	0.00973	CbGpPWpGaD
Flutamide—Headache—Budesonide—ulcerative colitis	0.000297	0.0017	CcSEcCtD
Flutamide—Hypertension—Prednisolone—ulcerative colitis	0.000297	0.0017	CcSEcCtD
Flutamide—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000294	0.00168	CcSEcCtD
Flutamide—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000293	0.00168	CcSEcCtD
Flutamide—AHR—Adipogenesis—PPARG—ulcerative colitis	0.00029	0.00948	CbGpPWpGaD
Flutamide—Hypertension—Hydrocortisone—ulcerative colitis	0.00029	0.00166	CcSEcCtD
Flutamide—Diarrhoea—Azathioprine—ulcerative colitis	0.00029	0.00166	CcSEcCtD
Flutamide—Discomfort—Prednisolone—ulcerative colitis	0.000289	0.00166	CcSEcCtD
Flutamide—Erythema—Dexamethasone—ulcerative colitis	0.000287	0.00164	CcSEcCtD
Flutamide—Erythema—Betamethasone—ulcerative colitis	0.000287	0.00164	CcSEcCtD
Flutamide—Malaise—Triamcinolone—ulcerative colitis	0.000285	0.00163	CcSEcCtD
Flutamide—Anxiety—Hydrocortisone—ulcerative colitis	0.000285	0.00163	CcSEcCtD
Flutamide—Malaise—Methylprednisolone—ulcerative colitis	0.000285	0.00163	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000284	0.00163	CcSEcCtD
Flutamide—Discomfort—Hydrocortisone—ulcerative colitis	0.000283	0.00162	CcSEcCtD
Flutamide—CYP1B1—smooth muscle tissue—ulcerative colitis	0.000282	0.0578	CbGeAlD
Flutamide—Nausea—Budesonide—ulcerative colitis	0.000282	0.00161	CcSEcCtD
Flutamide—Oedema—Prednisolone—ulcerative colitis	0.000281	0.00161	CcSEcCtD
Flutamide—Dizziness—Azathioprine—ulcerative colitis	0.00028	0.0016	CcSEcCtD
Flutamide—AR—epithelium—ulcerative colitis	0.000278	0.0568	CbGeAlD
Flutamide—Asthenia—Mesalazine—ulcerative colitis	0.000277	0.00158	CcSEcCtD
Flutamide—Oedema—Hydrocortisone—ulcerative colitis	0.000274	0.00157	CcSEcCtD
Flutamide—Hypertension—Triamcinolone—ulcerative colitis	0.000273	0.00156	CcSEcCtD
Flutamide—Pruritus—Mesalazine—ulcerative colitis	0.000273	0.00156	CcSEcCtD
Flutamide—Hypertension—Methylprednisolone—ulcerative colitis	0.000273	0.00156	CcSEcCtD
Flutamide—Vomiting—Azathioprine—ulcerative colitis	0.000269	0.00154	CcSEcCtD
Flutamide—Anxiety—Methylprednisolone—ulcerative colitis	0.000268	0.00153	CcSEcCtD
Flutamide—AR—smooth muscle tissue—ulcerative colitis	0.000268	0.0547	CbGeAlD
Flutamide—Rash—Azathioprine—ulcerative colitis	0.000267	0.00153	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000267	0.00153	CcSEcCtD
Flutamide—Dermatitis—Azathioprine—ulcerative colitis	0.000267	0.00153	CcSEcCtD
Flutamide—Skin disorder—Hydrocortisone—ulcerative colitis	0.000266	0.00153	CcSEcCtD
Flutamide—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000266	0.00153	CcSEcCtD
Flutamide—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000266	0.00153	CcSEcCtD
Flutamide—Discomfort—Triamcinolone—ulcerative colitis	0.000266	0.00152	CcSEcCtD
Flutamide—Discomfort—Methylprednisolone—ulcerative colitis	0.000266	0.00152	CcSEcCtD
Flutamide—Headache—Azathioprine—ulcerative colitis	0.000265	0.00152	CcSEcCtD
Flutamide—Diarrhoea—Mesalazine—ulcerative colitis	0.000264	0.00151	CcSEcCtD
Flutamide—AR—Nuclear Receptors—PPARG—ulcerative colitis	0.000263	0.00859	CbGpPWpGaD
Flutamide—Anorexia—Hydrocortisone—ulcerative colitis	0.000261	0.0015	CcSEcCtD
Flutamide—Confusional state—Methylprednisolone—ulcerative colitis	0.00026	0.00149	CcSEcCtD
Flutamide—Malaise—Betamethasone—ulcerative colitis	0.000259	0.00148	CcSEcCtD
Flutamide—Malaise—Dexamethasone—ulcerative colitis	0.000259	0.00148	CcSEcCtD
Flutamide—Oedema—Triamcinolone—ulcerative colitis	0.000258	0.00148	CcSEcCtD
Flutamide—Dizziness—Mesalazine—ulcerative colitis	0.000255	0.00146	CcSEcCtD
Flutamide—Insomnia—Prednisolone—ulcerative colitis	0.000254	0.00145	CcSEcCtD
Flutamide—CYP1B1—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000252	0.00821	CbGpPWpGaD
Flutamide—Nausea—Azathioprine—ulcerative colitis	0.000251	0.00144	CcSEcCtD
Flutamide—Skin disorder—Methylprednisolone—ulcerative colitis	0.00025	0.00143	CcSEcCtD
Flutamide—Erythema—Prednisone—ulcerative colitis	0.00025	0.00143	CcSEcCtD
Flutamide—Insomnia—Hydrocortisone—ulcerative colitis	0.000248	0.00142	CcSEcCtD
Flutamide—Hypertension—Dexamethasone—ulcerative colitis	0.000248	0.00142	CcSEcCtD
Flutamide—Hypertension—Betamethasone—ulcerative colitis	0.000248	0.00142	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—CDH1—ulcerative colitis	0.000246	0.00802	CbGpPWpGaD
Flutamide—Vomiting—Mesalazine—ulcerative colitis	0.000245	0.0014	CcSEcCtD
Flutamide—Anxiety—Betamethasone—ulcerative colitis	0.000244	0.0014	CcSEcCtD
Flutamide—Anxiety—Dexamethasone—ulcerative colitis	0.000244	0.0014	CcSEcCtD
Flutamide—Rash—Mesalazine—ulcerative colitis	0.000243	0.00139	CcSEcCtD
Flutamide—Dermatitis—Mesalazine—ulcerative colitis	0.000243	0.00139	CcSEcCtD
Flutamide—Headache—Mesalazine—ulcerative colitis	0.000242	0.00138	CcSEcCtD
Flutamide—Discomfort—Dexamethasone—ulcerative colitis	0.000241	0.00138	CcSEcCtD
Flutamide—Discomfort—Betamethasone—ulcerative colitis	0.000241	0.00138	CcSEcCtD
Flutamide—AR—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	0.00024	0.00784	CbGpPWpGaD
Flutamide—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000238	0.00137	CcSEcCtD
Flutamide—Fatigue—Hydrocortisone—ulcerative colitis	0.000236	0.00135	CcSEcCtD
Flutamide—Oedema—Betamethasone—ulcerative colitis	0.000234	0.00134	CcSEcCtD
Flutamide—Oedema—Dexamethasone—ulcerative colitis	0.000234	0.00134	CcSEcCtD
Flutamide—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000234	0.00765	CbGpPWpGaD
Flutamide—Insomnia—Triamcinolone—ulcerative colitis	0.000234	0.00134	CcSEcCtD
Flutamide—Insomnia—Methylprednisolone—ulcerative colitis	0.000233	0.00133	CcSEcCtD
Flutamide—Ill-defined disorder—Prednisone—ulcerative colitis	0.000232	0.00133	CcSEcCtD
Flutamide—Feeling abnormal—Prednisolone—ulcerative colitis	0.000231	0.00133	CcSEcCtD
Flutamide—Anaemia—Prednisone—ulcerative colitis	0.000231	0.00132	CcSEcCtD
Flutamide—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000229	0.00131	CcSEcCtD
Flutamide—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000229	0.00131	CcSEcCtD
Flutamide—Nausea—Mesalazine—ulcerative colitis	0.000229	0.00131	CcSEcCtD
Flutamide—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000226	0.00129	CcSEcCtD
Flutamide—CYP1B1—lymphoid tissue—ulcerative colitis	0.000226	0.0462	CbGeAlD
Flutamide—Malaise—Prednisone—ulcerative colitis	0.000225	0.00129	CcSEcCtD
Flutamide—Anorexia—Dexamethasone—ulcerative colitis	0.000223	0.00128	CcSEcCtD
Flutamide—Anorexia—Betamethasone—ulcerative colitis	0.000223	0.00128	CcSEcCtD
Flutamide—CYP1B1—digestive system—ulcerative colitis	0.000223	0.0456	CbGeAlD
Flutamide—Fatigue—Triamcinolone—ulcerative colitis	0.000223	0.00128	CcSEcCtD
Flutamide—Fatigue—Methylprednisolone—ulcerative colitis	0.000222	0.00127	CcSEcCtD
Flutamide—CYP1A1—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000221	0.00722	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.00022	0.00718	CbGpPWpGaD
Flutamide—Hypertension—Prednisone—ulcerative colitis	0.000216	0.00124	CcSEcCtD
Flutamide—AR—lymphoid tissue—ulcerative colitis	0.000214	0.0437	CbGeAlD
Flutamide—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000213	0.00122	CcSEcCtD
Flutamide—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000212	0.00122	CcSEcCtD
Flutamide—Anxiety—Prednisone—ulcerative colitis	0.000212	0.00121	CcSEcCtD
Flutamide—Insomnia—Betamethasone—ulcerative colitis	0.000212	0.00121	CcSEcCtD
Flutamide—Insomnia—Dexamethasone—ulcerative colitis	0.000212	0.00121	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000211	0.00121	CcSEcCtD
Flutamide—AR—digestive system—ulcerative colitis	0.000211	0.0432	CbGeAlD
Flutamide—Discomfort—Prednisone—ulcerative colitis	0.00021	0.0012	CcSEcCtD
Flutamide—AR—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.000208	0.00678	CbGpPWpGaD
Flutamide—CYP1A1—epithelium—ulcerative colitis	0.000207	0.0424	CbGeAlD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—VDR—ulcerative colitis	0.000206	0.00672	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—PPARG—ulcerative colitis	0.000205	0.00669	CbGpPWpGaD
Flutamide—Oedema—Prednisone—ulcerative colitis	0.000204	0.00117	CcSEcCtD
Flutamide—Decreased appetite—Betamethasone—ulcerative colitis	0.000204	0.00117	CcSEcCtD
Flutamide—Decreased appetite—Dexamethasone—ulcerative colitis	0.000204	0.00117	CcSEcCtD
Flutamide—Fatigue—Betamethasone—ulcerative colitis	0.000202	0.00116	CcSEcCtD
Flutamide—Fatigue—Dexamethasone—ulcerative colitis	0.000202	0.00116	CcSEcCtD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—IL10—ulcerative colitis	0.0002	0.00654	CbGpPWpGaD
Flutamide—Skin disorder—Prednisone—ulcerative colitis	0.000198	0.00114	CcSEcCtD
Flutamide—Asthenia—Hydrocortisone—ulcerative colitis	0.000197	0.00113	CcSEcCtD
Flutamide—CYP2C19—digestive system—ulcerative colitis	0.000196	0.04	CbGeAlD
Flutamide—Anorexia—Prednisone—ulcerative colitis	0.000194	0.00111	CcSEcCtD
Flutamide—CYP1A1—Estrogen Receptor Pathway—STAT3—ulcerative colitis	0.000194	0.00634	CbGpPWpGaD
Flutamide—Pruritus—Hydrocortisone—ulcerative colitis	0.000194	0.00111	CcSEcCtD
Flutamide—Feeling abnormal—Betamethasone—ulcerative colitis	0.000193	0.00111	CcSEcCtD
Flutamide—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000193	0.00111	CcSEcCtD
Flutamide—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000188	0.00107	CcSEcCtD
Flutamide—Dizziness—Prednisolone—ulcerative colitis	0.000186	0.00106	CcSEcCtD
Flutamide—AR—Notch-mediated HES/HEY network—JAK2—ulcerative colitis	0.000185	0.00605	CbGpPWpGaD
Flutamide—Asthenia—Triamcinolone—ulcerative colitis	0.000185	0.00106	CcSEcCtD
Flutamide—Asthenia—Methylprednisolone—ulcerative colitis	0.000185	0.00106	CcSEcCtD
Flutamide—CYP1B1—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000185	0.00603	CbGpPWpGaD
Flutamide—Insomnia—Prednisone—ulcerative colitis	0.000185	0.00106	CcSEcCtD
Flutamide—Pruritus—Triamcinolone—ulcerative colitis	0.000183	0.00105	CcSEcCtD
Flutamide—Pruritus—Methylprednisolone—ulcerative colitis	0.000182	0.00104	CcSEcCtD
Flutamide—Dizziness—Hydrocortisone—ulcerative colitis	0.000181	0.00104	CcSEcCtD
Flutamide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000181	0.00591	CbGpPWpGaD
Flutamide—CYP2C19—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000181	0.00591	CbGpPWpGaD
Flutamide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000181	0.0059	CbGpPWpGaD
Flutamide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.00018	0.00589	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—STAT3—ulcerative colitis	0.000178	0.00582	CbGpPWpGaD
Flutamide—Decreased appetite—Prednisone—ulcerative colitis	0.000177	0.00102	CcSEcCtD
Flutamide—Rash—Prednisolone—ulcerative colitis	0.000177	0.00101	CcSEcCtD
Flutamide—Dermatitis—Prednisolone—ulcerative colitis	0.000177	0.00101	CcSEcCtD
Flutamide—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000176	0.00101	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	0.000176	0.00574	CbGpPWpGaD
Flutamide—Fatigue—Prednisone—ulcerative colitis	0.000176	0.00101	CcSEcCtD
Flutamide—Headache—Prednisolone—ulcerative colitis	0.000176	0.00101	CcSEcCtD
Flutamide—AR—Notch-mediated HES/HEY network—CD4—ulcerative colitis	0.000176	0.00574	CbGpPWpGaD
Flutamide—Constipation—Prednisone—ulcerative colitis	0.000174	0.000999	CcSEcCtD
Flutamide—Vomiting—Hydrocortisone—ulcerative colitis	0.000174	0.000999	CcSEcCtD
Flutamide—Rash—Hydrocortisone—ulcerative colitis	0.000173	0.00099	CcSEcCtD
Flutamide—Dermatitis—Hydrocortisone—ulcerative colitis	0.000173	0.000989	CcSEcCtD
Flutamide—Headache—Hydrocortisone—ulcerative colitis	0.000172	0.000984	CcSEcCtD
Flutamide—Dizziness—Triamcinolone—ulcerative colitis	0.000171	0.000978	CcSEcCtD
Flutamide—Dizziness—Methylprednisolone—ulcerative colitis	0.00017	0.000976	CcSEcCtD
Flutamide—Feeling abnormal—Prednisone—ulcerative colitis	0.000168	0.000963	CcSEcCtD
Flutamide—Asthenia—Dexamethasone—ulcerative colitis	0.000168	0.000963	CcSEcCtD
Flutamide—Asthenia—Betamethasone—ulcerative colitis	0.000168	0.000963	CcSEcCtD
Flutamide—Nausea—Prednisolone—ulcerative colitis	0.000167	0.000955	CcSEcCtD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000166	0.00543	CbGpPWpGaD
Flutamide—CYP1B1—liver—ulcerative colitis	0.000166	0.034	CbGeAlD
Flutamide—Pruritus—Dexamethasone—ulcerative colitis	0.000166	0.000949	CcSEcCtD
Flutamide—Pruritus—Betamethasone—ulcerative colitis	0.000166	0.000949	CcSEcCtD
Flutamide—AHR—Adipogenesis—TGFB1—ulcerative colitis	0.000165	0.00539	CbGpPWpGaD
Flutamide—Vomiting—Triamcinolone—ulcerative colitis	0.000164	0.00094	CcSEcCtD
Flutamide—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000164	0.00535	CbGpPWpGaD
Flutamide—Vomiting—Methylprednisolone—ulcerative colitis	0.000164	0.000938	CcSEcCtD
Flutamide—Nausea—Hydrocortisone—ulcerative colitis	0.000163	0.000933	CcSEcCtD
Flutamide—Rash—Triamcinolone—ulcerative colitis	0.000163	0.000933	CcSEcCtD
Flutamide—Dermatitis—Triamcinolone—ulcerative colitis	0.000163	0.000932	CcSEcCtD
Flutamide—Rash—Methylprednisolone—ulcerative colitis	0.000162	0.00093	CcSEcCtD
Flutamide—Dermatitis—Methylprednisolone—ulcerative colitis	0.000162	0.00093	CcSEcCtD
Flutamide—Headache—Triamcinolone—ulcerative colitis	0.000162	0.000927	CcSEcCtD
Flutamide—Headache—Methylprednisolone—ulcerative colitis	0.000161	0.000924	CcSEcCtD
Flutamide—Diarrhoea—Betamethasone—ulcerative colitis	0.00016	0.000918	CcSEcCtD
Flutamide—Diarrhoea—Dexamethasone—ulcerative colitis	0.00016	0.000918	CcSEcCtD
Flutamide—CYP1A2—digestive system—ulcerative colitis	0.00016	0.0327	CbGeAlD
Flutamide—CYP1A1—digestive system—ulcerative colitis	0.000158	0.0322	CbGeAlD
Flutamide—AR—liver—ulcerative colitis	0.000157	0.0322	CbGeAlD
Flutamide—AR—Gene Expression—ZFP90—ulcerative colitis	0.000155	0.00507	CbGpPWpGaD
Flutamide—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000155	0.00506	CbGpPWpGaD
Flutamide—Dizziness—Betamethasone—ulcerative colitis	0.000155	0.000887	CcSEcCtD
Flutamide—Dizziness—Dexamethasone—ulcerative colitis	0.000155	0.000887	CcSEcCtD
Flutamide—AHR—Adipogenesis—TNF—ulcerative colitis	0.000154	0.00504	CbGpPWpGaD
Flutamide—CYP3A5—digestive system—ulcerative colitis	0.000154	0.0315	CbGeAlD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.000153	0.00501	CbGpPWpGaD
Flutamide—Nausea—Triamcinolone—ulcerative colitis	0.000153	0.000878	CcSEcCtD
Flutamide—Nausea—Methylprednisolone—ulcerative colitis	0.000153	0.000877	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	0.000151	0.00494	CbGpPWpGaD
Flutamide—Vomiting—Dexamethasone—ulcerative colitis	0.000149	0.000853	CcSEcCtD
Flutamide—Vomiting—Betamethasone—ulcerative colitis	0.000149	0.000853	CcSEcCtD
Flutamide—AR—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.000148	0.00483	CbGpPWpGaD
Flutamide—Rash—Betamethasone—ulcerative colitis	0.000148	0.000846	CcSEcCtD
Flutamide—Rash—Dexamethasone—ulcerative colitis	0.000148	0.000846	CcSEcCtD
Flutamide—Dermatitis—Betamethasone—ulcerative colitis	0.000148	0.000845	CcSEcCtD
Flutamide—Dermatitis—Dexamethasone—ulcerative colitis	0.000148	0.000845	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	0.000147	0.0048	CbGpPWpGaD
Flutamide—Headache—Dexamethasone—ulcerative colitis	0.000147	0.000841	CcSEcCtD
Flutamide—Headache—Betamethasone—ulcerative colitis	0.000147	0.000841	CcSEcCtD
Flutamide—Asthenia—Prednisone—ulcerative colitis	0.000146	0.000838	CcSEcCtD
Flutamide—CYP2C19—liver—ulcerative colitis	0.000146	0.0298	CbGeAlD
Flutamide—Pruritus—Prednisone—ulcerative colitis	0.000144	0.000827	CcSEcCtD
Flutamide—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000141	0.0046	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.00014	0.00458	CbGpPWpGaD
Flutamide—Diarrhoea—Prednisone—ulcerative colitis	0.00014	0.0008	CcSEcCtD
Flutamide—Nausea—Betamethasone—ulcerative colitis	0.000139	0.000797	CcSEcCtD
Flutamide—Nausea—Dexamethasone—ulcerative colitis	0.000139	0.000797	CcSEcCtD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—ulcerative colitis	0.000138	0.00451	CbGpPWpGaD
Flutamide—CYP1B1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000138	0.00449	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000137	0.00447	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.000136	0.00445	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—STAT3—ulcerative colitis	0.000136	0.00444	CbGpPWpGaD
Flutamide—Dizziness—Prednisone—ulcerative colitis	0.000135	0.000773	CcSEcCtD
Flutamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000134	0.00439	CbGpPWpGaD
Flutamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000134	0.00438	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—PTGS1—ulcerative colitis	0.000134	0.00436	CbGpPWpGaD
Flutamide—Vomiting—Prednisone—ulcerative colitis	0.00013	0.000743	CcSEcCtD
Flutamide—Rash—Prednisone—ulcerative colitis	0.000129	0.000737	CcSEcCtD
Flutamide—Dermatitis—Prednisone—ulcerative colitis	0.000129	0.000736	CcSEcCtD
Flutamide—Headache—Prednisone—ulcerative colitis	0.000128	0.000732	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	0.000128	0.00417	CbGpPWpGaD
Flutamide—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000127	0.00414	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—IL6—ulcerative colitis	0.000124	0.00406	CbGpPWpGaD
Flutamide—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	0.000124	0.00404	CbGpPWpGaD
Flutamide—Nausea—Prednisone—ulcerative colitis	0.000121	0.000694	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	0.000121	0.00394	CbGpPWpGaD
Flutamide—CYP1A2—liver—ulcerative colitis	0.000119	0.0244	CbGeAlD
Flutamide—AR—SIDS Susceptibility Pathways—IL10—ulcerative colitis	0.000119	0.00387	CbGpPWpGaD
Flutamide—CYP1A1—liver—ulcerative colitis	0.000117	0.024	CbGeAlD
Flutamide—CYP3A4—digestive system—ulcerative colitis	0.000116	0.0237	CbGeAlD
Flutamide—CYP3A5—liver—ulcerative colitis	0.000115	0.0235	CbGeAlD
Flutamide—CYP1A1—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000114	0.00371	CbGpPWpGaD
Flutamide—CYP1A1—Oxidative Stress—NFKB1—ulcerative colitis	0.000111	0.00361	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—ulcerative colitis	0.000111	0.00361	CbGpPWpGaD
Flutamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000109	0.00356	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—RELA—ulcerative colitis	0.000108	0.00352	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.000106	0.00347	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	0.000104	0.00339	CbGpPWpGaD
Flutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000104	0.00339	CbGpPWpGaD
Flutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000104	0.00338	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—MMP1—ulcerative colitis	0.000103	0.00338	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—ulcerative colitis	0.0001	0.00327	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	9.93e-05	0.00324	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	9.93e-05	0.00324	CbGpPWpGaD
Flutamide—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	9.88e-05	0.00323	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—TP53—ulcerative colitis	9.6e-05	0.00313	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	9.45e-05	0.00309	CbGpPWpGaD
Flutamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	9.35e-05	0.00305	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	9.32e-05	0.00304	CbGpPWpGaD
Flutamide—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	9.31e-05	0.00304	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	9.06e-05	0.00296	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—IL6—ulcerative colitis	8.78e-05	0.00287	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—PTGS1—ulcerative colitis	8.71e-05	0.00284	CbGpPWpGaD
Flutamide—CYP3A4—liver—ulcerative colitis	8.62e-05	0.0176	CbGeAlD
Flutamide—CYP1A1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	8.48e-05	0.00277	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	8.43e-05	0.00275	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	8.4e-05	0.00274	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CDH1—ulcerative colitis	8.32e-05	0.00271	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—HNF4A—ulcerative colitis	8.27e-05	0.0027	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—PTGS1—ulcerative colitis	8.23e-05	0.00269	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—STAT3—ulcerative colitis	8.17e-05	0.00267	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MAML2—ulcerative colitis	8.06e-05	0.00263	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	7.86e-05	0.00257	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.63e-05	0.00249	CbGpPWpGaD
Flutamide—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	7.25e-05	0.00237	CbGpPWpGaD
Flutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	7.22e-05	0.00236	CbGpPWpGaD
Flutamide—AR—Gene Expression—NR5A2—ulcerative colitis	7.12e-05	0.00233	CbGpPWpGaD
Flutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	6.94e-05	0.00226	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	6.74e-05	0.0022	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	6.55e-05	0.00214	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	6.48e-05	0.00212	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	6.22e-05	0.00203	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	6.12e-05	0.002	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	6.12e-05	0.002	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	6.03e-05	0.00197	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	5.95e-05	0.00194	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	5.95e-05	0.00194	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	5.8e-05	0.00189	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	5.78e-05	0.00189	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—PPARG—ulcerative colitis	5.73e-05	0.00187	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	5.68e-05	0.00186	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	5.61e-05	0.00183	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CHP1—ulcerative colitis	5.48e-05	0.00179	CbGpPWpGaD
Flutamide—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	5.4e-05	0.00176	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	5.37e-05	0.00175	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	5.35e-05	0.00175	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	5.25e-05	0.00171	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—VDR—ulcerative colitis	5.15e-05	0.00168	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.13e-05	0.00168	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	5.01e-05	0.00164	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	4.93e-05	0.00161	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—DLD—ulcerative colitis	4.73e-05	0.00154	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—TNF—ulcerative colitis	4.51e-05	0.00147	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	4.18e-05	0.00136	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	4.11e-05	0.00134	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	4.08e-05	0.00133	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	4.05e-05	0.00132	CbGpPWpGaD
Flutamide—AR—Gene Expression—HNF4A—ulcerative colitis	3.98e-05	0.0013	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	3.9e-05	0.00127	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	3.9e-05	0.00127	CbGpPWpGaD
Flutamide—AR—Gene Expression—MAML2—ulcerative colitis	3.88e-05	0.00127	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	3.87e-05	0.00126	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	3.84e-05	0.00125	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—IL6—ulcerative colitis	3.64e-05	0.00119	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—PPARG—ulcerative colitis	3.59e-05	0.00117	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CHP1—ulcerative colitis	3.57e-05	0.00117	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	3.38e-05	0.0011	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CHP1—ulcerative colitis	3.37e-05	0.0011	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.16e-05	0.00103	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—DLD—ulcerative colitis	3.08e-05	0.00101	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—DLD—ulcerative colitis	2.91e-05	0.000951	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CHP1—ulcerative colitis	2.76e-05	0.000901	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.59e-05	0.000844	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.5e-05	0.000816	CbGpPWpGaD
Flutamide—AR—Gene Expression—VDR—ulcerative colitis	2.48e-05	0.000809	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—DLD—ulcerative colitis	2.38e-05	0.000778	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS1—ulcerative colitis	2.29e-05	0.000746	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.25e-05	0.000734	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CHP1—ulcerative colitis	2.15e-05	0.000702	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CALM3—ulcerative colitis	2.06e-05	0.000672	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.02e-05	0.000658	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.97e-05	0.000642	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—DLD—ulcerative colitis	1.86e-05	0.000606	CbGpPWpGaD
Flutamide—AR—Gene Expression—PPARG—ulcerative colitis	1.73e-05	0.000564	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.66e-05	0.000542	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ABCB1—ulcerative colitis	1.6e-05	0.000523	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.54e-05	0.000503	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ADCY5—ulcerative colitis	1.49e-05	0.000487	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS1—ulcerative colitis	1.49e-05	0.000486	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—DLD—ulcerative colitis	1.43e-05	0.000468	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS1—ulcerative colitis	1.41e-05	0.00046	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.38e-05	0.000452	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CALM3—ulcerative colitis	1.34e-05	0.000438	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CALM3—ulcerative colitis	1.27e-05	0.000414	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.26e-05	0.000411	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.21e-05	0.000395	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS1—ulcerative colitis	1.15e-05	0.000376	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.13e-05	0.00037	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PPARG—ulcerative colitis	1.11e-05	0.000364	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ABCB1—ulcerative colitis	1.04e-05	0.000341	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CALM3—ulcerative colitis	1.04e-05	0.000339	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALB—ulcerative colitis	1e-05	0.000327	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.91e-06	0.000324	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ABCB1—ulcerative colitis	9.86e-06	0.000322	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	9.82e-06	0.000321	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ADCY5—ulcerative colitis	9.73e-06	0.000318	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ADCY5—ulcerative colitis	9.2e-06	0.0003	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS1—ulcerative colitis	8.98e-06	0.000293	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	8.83e-06	0.000288	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS2—ulcerative colitis	8.76e-06	0.000286	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CALM3—ulcerative colitis	8.08e-06	0.000264	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCB1—ulcerative colitis	8.07e-06	0.000263	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	7.72e-06	0.000252	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ADCY5—ulcerative colitis	7.52e-06	0.000246	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PPARG—ulcerative colitis	7.26e-06	0.000237	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS1—ulcerative colitis	6.93e-06	0.000226	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PPARG—ulcerative colitis	6.86e-06	0.000224	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALB—ulcerative colitis	6.53e-06	0.000213	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCB1—ulcerative colitis	6.29e-06	0.000205	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CALM3—ulcerative colitis	6.24e-06	0.000204	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALB—ulcerative colitis	6.17e-06	0.000201	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ADCY5—ulcerative colitis	5.86e-06	0.000191	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS2—ulcerative colitis	5.71e-06	0.000186	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PPARG—ulcerative colitis	5.61e-06	0.000183	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS2—ulcerative colitis	5.39e-06	0.000176	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALB—ulcerative colitis	5.05e-06	0.000165	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.85e-06	0.000158	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.52e-06	0.000148	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS2—ulcerative colitis	4.41e-06	0.000144	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PPARG—ulcerative colitis	4.37e-06	0.000143	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALB—ulcerative colitis	3.93e-06	0.000128	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS2—ulcerative colitis	3.44e-06	0.000112	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.37e-06	0.00011	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALB—ulcerative colitis	3.03e-06	9.91e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.65e-06	8.67e-05	CbGpPWpGaD
